HCMTDirexion HCM Tactical Enhanced U.S. Equity Strategy ETF
Seeks capital appreciation.
By Direxion Funds · Launched 2023
Annual Cost
1.18%
#5,651 of 6,040 · expensive
Fund Size
$600M
#1,519 of 6,040 · large
Return (1Y)
+13.8%
Track Record
3 years
#2,982 of 6,040 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$11,412+14.1%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundHoldings
By weightConcentration
Top 10 holdings = 73.2% of fundconcentrated
DREYFUS GOVERNMENT CASH MANAGE
41.5%
GOLDMAN SACHS LIQ ES FD A
12.9%
DREYFUS
5.0%
NVIDIA Corp.
3.1%
Apple Inc.
2.6%
Microsoft Corp.
2.0%
N/A
1.8%
Amazon.com, Inc.
1.7%
Alphabet Inc.
1.4%
Broadcom Inc
1.3%
Asset allocation
Other
54.3%
Stocks
40.3%
Cash
5.4%
By sector
Technology
38.7%
Financial Services
12.1%
Communication
9.5%
Consumer Cyclical
9.3%
Healthcare
9.3%
Industrials
7.8%
Consumer Defensive
4.5%
Energy
3.5%
Other
5.5%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
28.9%High
Year-on-year price swings
Max drawdown
-36.3%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.60Decent risk-adjusted returns
Sortino (3Y)
0.82Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks capital appreciation.
- Strategy
- Actively managed fund aiming for enhanced returns correlated to U.S. equity markets. Invests in U.S. equity securities and cash equivalents, utilizing a proprietary quantitative model to adjust allocations based on market trends. May leverage up to 200% of net assets across various sectors, including health care.
- Inception date
- June 21, 2023
- Fund family
- Direxion Funds
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save HCMT to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-18